Follow us
Nigeria Health Watch
Follow us:
Subscribe to our Newsletter
breadcrumb banner

Lassa fever Clinical Trials

Search

Categories

Recent Posts

Post Image

WHX in Lagos to highlight pathways for localising West Africa’s health supply chain

May 13, 2026
Post Image

In Nigeria and Tanzania, Simulation Training Is Changing How Birth Emergencies Are Managed

May 12, 2026
Post Image

One Million More Midwives: The Smartest Investment for Safer Births in a Shrinking Aid Landscape

May 11, 2026
Post Image

Curated Conversations: Isra Chaker on Reimagining Maternal Health Philanthropy and Saving Mothers’ Lives

May 11, 2026
Post Image

Beauty Without Burden: Why Nigeria Must Keep Lead Out of Cosmetics

May 11, 2026
Blog Image
By | December 4, 2025

First Volunteer Receives Lassa Fever Vaccine in Cutting-edge Oxford Trial

The first volunteer has received a dose in a first-in-human trial of a Lassa vaccine, marking a major milestone in the fight against the deadly virus. The trial, conducted by the Oxford Vaccine Group, and funded by the Coalition for Epidemic Preparedness Innovations (CEPI), will assess the safety and immune response of the ChAdOx1 Lassa […]

Read More
Blog Image 12 Nov

Lassa Fever Clinical Trials Strengthening Nigeria’s Health Sovereignty

By | November 12, 2025

Olaoluwa Olatunde and Aderonke Popoola (Lead writers) Nigeria continues to bear a high burden of infectious diseases, including Lassa fever, malaria, and tuberculosis. However, clinical trials capacity for therapeutics and vaccines in the country remains limited, emphasising the urgent need to strengthen local trial infrastructure and building technical expertise to ensure equitable access the vaccines […]

Read More